Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020)
Biodesix (BDSX) posted Preferred Stock Liabilities of $194.0 million for Q3 2020, little changed quarter-over-quarter from $194.0 million in Q2 2020, and little changed year-on-year from $194.0 million in Q4 2019.
Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends
Biodesix (BDSX) has reported Preferred Stock Liabilities for 2 consecutive years, with $194.0 million the latest figure, recorded in Q3 2020.
- Preferred Stock Liabilities for Q3 2020 came in at $194.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2020 was $194.0 million (changed 0.0% YoY), and the FY2019 annual result was $194.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $194.0 million for Q3 2020 at Biodesix, roughly flat from $194.0 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $194.0 million in Q3 2019 and troughed at $194.0 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Biodesix | 236.57 Mn | 211.00 Mn | 21.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 193.96 Mn |
| Jun 30, 2020 | 193.96 Mn |
| Mar 31, 2020 | 193.96 Mn |
| Dec 31, 2019 | 193.96 Mn |
| Sep 30, 2019 | 193.96 Mn |